Company: KNRX
Filing Date: 2025-06-12
Form Type: F-1/A
Source: 0001641172-25-014801
Chunk: 228

Company: KNOREX LTD.
Filing Date: 2025-06-12
Form: F-1/A
Chunk 228
---
 deducting underwriting discounts, commissions and the estimated offering expenses payable by us and based upon an assumed initial offering price of US$4.75 per Class A ordinary share (the mid-point of the estimated public offering price range shown on the front cover of this prospectus).

Concurrent with our initial public offering, our Class A ordinary shares were listed on the NYSE American under the symbol “KNRX.”

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, as amended, and a “foreign private issuer” under applicable U.S. federal securities laws and, as such, are eligible for reduced public company reporting requirements. See “Prospectus Summary – Implications of Being an Emerging Growth Company” and “Prospectus Summary – Implications of Being a Foreign Private Issuer” beginning on page 8 of the public offering prospectus for more information.

KNOREX LTD. was incorporated as an exempted company under the laws of the Cayman Islands without any operations of its own. We conduct our operations primarily in the United States, Singapore, Vietnam, India and Malaysia through our operating subsidiaries. The Class A ordinary shares offered in this offering are shares of the Cayman Islands holding company, instead of shares of our operating subsidiaries. Investors in this this offering will not directly hold equity interests in our operating subsidiaries. This structure involves unique risks to investors. For a detailed discussion of risks associated with our corporate structure, see “Risk Factors – Risks Relating to Our Ordinary Shares and This Offering” beginning on page 27 of the public offering prospectus.

Investing in our securities involves a high degree of risks. See “Risk Factors” beginning on page 12 of this public offering prospectus for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is _______, 2025</div>

<div align='center'>THE OFFERING</div>

| Class                                                      
 A Ordinary Shares being offered by the Resale Shareholders |     | 1,417,250                                                                                                                                   
 Class A Ordinary Shares                                                                                                                     |
| Class                                                      
 A Ordinary Shares outstanding after this offering          |     | 25,642,538                                                                                                                                  
 Class                                                                                                                                       
 A Ordinary Shares, assuming